Following treatment (days 8–26), a reduction in tumor SGR was observed across all treatment groups compared to PTX only treated animals, although the differences between the control and cannabinoid groups did not reach statistical significance (p = 0.073, p = 0.39) ( Figure 6 ).
← all excerpts
Multifaced roles of cannabinoid therapy in cancer: balancing analgesia, antitumor potential, and systemic toxicity.
1
0.0730
0.0730